Reposted by Mirjam Christ-Crain
Identification of individuals at high risk for #MEN1 can be facilitated by genetic testing of patients and their first-degree relatives, and undertaking periodic clinical, biochemical, and radiological screening in patients and MEN1 mutation carriers www.thelancet.com/journals/lan...
#FREE to read
thelancet.com
Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice
Multiple endocrine neoplasia type 1 (MEN1) is characterised by combined occurrence
of parathyroid tumours, duodenopancreatic neuroendocrine tumours, and anterior pituitary
adenomas. Some patients migh...
